Organization
Burzynski Research Institute
4 clinical trials
Clinical trial
Phase II Study of Antineoplastons A10 and AS2-1 in Children With Low Grade AstrocytomaStatus: Completed, Estimated PCD: 2004-07-01
Clinical trial
A Randomized Phase 3 Study of Combination Antineoplaston Therapy [Antineoplastons A10 (Atengenal) and AS2-1 (Astugenal)] Plus Radiation Therapy vs. Radiation Therapy Only in Subjects With Newly Diagnosed Diffuse, Intrinsic, Brainstem GliomaStatus: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
A Phase 2 Study of Atengenal (A-10) and Astugenal (AS2-1) in Diffuse, Intrinsic Pontine Glioma (DIPG)Status: , Estimated PCD: 2028-03-01
Clinical trial
A Controlled, Study of the Effect of Combination Antineoplaston Therapy [Atengenal (A10) and Astugenal (AS2-1)] on the QT/QTc Interval In Subjects With Newly Diagnosed Diffuse, Intrinsic, Brainstem GliomaStatus: Not yet recruiting, Estimated PCD: 2025-12-01